Fintech

The Ascension of Asensus in Performance-Guided Surgery

Published

2 years ago

on

Key commercial and regulatory milestones expected during the second half of 2022

New York, New York–(Newsfile Corp. – June 28, 2022) – PCG Digital — In a recent interview, Shameze Rampertab, CFO of Asensus Surgical (NYSE American: ASXC), shared more of the Performance-Guided Surgery™ company’s 2022 plans and progress.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/129197

Related Topics:

Trending

Exit mobile version